Longaeva
Overview
A venture capital firm that invests in companies developing therapeutics, diagnostics, and tools to extend healthy human lifespan.
Portfolio Companies
5
Website
longaeva.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nscale | Aug 2026 | Convertible Debt | Co-investor |
| Imperative Care | Mar 2026 | VC Round | Co-investor |
| Gala Therapeutics | Sep 2025 | Series C | Co-investor |
| Galvanize Therapeutics | Sep 2025 | Series C | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Longaeva based?
Longaeva is headquartered in Glendale, California, United States.
When was Longaeva founded?
Founding year information for Longaeva is not publicly available.
How many portfolio companies does Longaeva have?
Longaeva has 5 portfolio companies in Caplight's dataset.
What are some companies in Longaeva's portfolio?
Recent investments visible on Caplight include Nscale, Imperative Care, Gala Therapeutics, Galvanize Therapeutics.
What was Longaeva's most recent investment?
Longaeva's most recent investment on Caplight was in Nscale in 2026.
What sectors does Longaeva focus on?
Longaeva focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Telecommunications & Networking.
What company stages does Longaeva focus on?
Longaeva typically invests at the Mid stage.
What is Longaeva's AUM?
Longaeva's assets under management are estimated at over $490.6M.